Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

Affiliations

• ¹ ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
• ² UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France.
• ³ KYomed INNOV, Montpellier, France.
• ⁴ MACVIA-France, Fondation partenariale FMC VIA-LR, Montpellier, France.
• ⁵ Medical Consulting Czarlewski, Levallois, France.
• ⁶ Medical Communications Consultant, MedScript, Dundalk, and OPC, Cambridge, United Kingdom.
• ⁷ Center for Health Technology and Services Research-CINTESIS, Faculdade de Medicina, Universidade do Porto, and Medida, Porto, Portugal.
• ⁸ UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal.
• ⁹ Institute of Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, and the Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal.
• ¹⁰ Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal.
• ¹¹ Allergy Unit, CUF-Porto Hospital and Institute, and the Center for Research in Health Technologies and information systems CINTESIS, Universidade do Porto, Porto, Portugal.
• ¹² Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
• ¹³ CIRFF, Federico II University, Naples, Italy.
• ¹⁴ Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
• ¹⁵ Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
• ¹⁶ ProAR-Nucleo de Excelencia em Asma, Federal University of Bahia, and the WHO GARD Planning Group, Brazil.
• ¹⁷ Pulmonary Division, Heart Institute (InCor), Hospital da Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil.
• ¹⁸ Department of Internal Medicine and Allergy Clinic of Professor Polydoro Ernani de São Thiago University Hospital, Federal University of Santa Catarina (UFSC), Florianopolis, Brazil.
• ¹⁹ Center of Excellence in Asthma and Allergy, Hospital Médica Sur, México City, Mexico.
• ²⁰ Hospital General Region 1, Dr Carlos Mc Gregor Sanchez Navarro" IMSS, Mexico City, Mexico.
• ²¹ Clinic of Children's Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
• ²² Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
• ²³ Vilnius University Institute of Clinical Medicine, Clinic of Children's Diseases, and the Institute of Health Sciences, Department of Public Health, Vilnius, Lithuania; European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.
• ²⁴ Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
• ²⁵ Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
• ²⁶ Center for Rhinology and Allergology, Wiesbaden, Department of Otorhinolaryngology, Head and Neck Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
• ²⁷ Institute of Medical Statistics, and Computational Biology, Medical Faculty, University of Cologne, and CRI-Clinical Research International, Hamburg, Germany.
• ²⁸ Department of Otorhinolaryngology, Head and Neck Surgery, Section for Rhinology and Allergy, University Hospital Marburg, Phillipps-Universität, Marburg, Germany.
• ²⁹ Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM and UPMC Sorbonne Université, Medical School Saint Antoine, Paris, France.
• ³⁰ Allergist, La Rochelle, France.
• ³¹ Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
• ³² Allergist, Reims, France.
• ³³ Allergy Section, Department of Internal Medicine, Hospital Vall'dHebron & ARADyAL Research Network, Barcelona, Spain.
• ³⁴ Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, and Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
• ³⁵ Pneumology and Allergy Department CIBERES and Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, University of Barcelona, Barcelona, Spain.
• ³⁶ Department of Internal Medicine, Medical University of Graz, Graz, Austria.
• ³⁷ Department of ENT, Medical University of Graz, Graz, Austria.
• ³⁸ Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, the Netherlands.
• ³⁹ Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, the Netherlands.
• ⁴⁰ iQ4U Consultants, London, United Kingdom.
• ⁴¹ Allergy and Respiratory Research Group, University of Edinburgh, Edinburgh, United Kingdom.
• ⁴² Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom.
• ⁴³ Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
• ⁴⁴ Department of Lung Diseases and Clinical Immunology, University of Turku and Terveystalo allergy clinic, Turku, Finland.
• ⁴⁵ Allergy Unit "D Kalogeromitros", 2nd Department of Dermatology and Venereology, National & Kapodistrian University of Athens, "Attikon" University Hospital, Athens, Greece.
• ⁴⁶ Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, and UK Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.
• ⁴⁷ Department of Otorhinolaryngology University of Crete School of Medicine, Heraklion, Greece.
• ⁴⁸ Allergy Department, Athens Naval Hospital, Athens, Greece.
• ⁴⁹ Eskisehir Osmangazi University, Medical Faculty, ENT Department, Eskisehir, Turkey.
• ⁵⁰ Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey.
• ⁵¹ Department of Pulmonary Diseases, Celal Bayar University, Faculty of Medicine, Manisa (and the GARD Executive Committee), Manisa, Turkey.
• ⁵² Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia; Woolcock Emphysema Centre and Local Health District, Glebe, Australia.
• ⁵³ Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, and the Department of Immunology, Monash University, Melbourne, Australia.
• ⁵⁴ Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
• ⁵⁵ Department of Otorhinolaryngology, University Hospitals Leuven, and the Academic Medical Center, University of Amsterdam, and Euforea, Brussels, Belgium.
• ⁵⁶ European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium.
• ⁵⁷ Department of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark.
• ⁵⁸ Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, and Sach's Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
• ⁵⁹ Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
• ⁶⁰ Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden.
• ⁶¹ Peercode BV, Geldermalsen, the Netherlands.
• ⁶² Transylvania University Brasov, Brasov, Romania.
• ⁶³ Department of Allergy and Immunology, Hospital Quirón Bizkaia, Erandio, Spain.
• ⁶⁴ Section of Allergy and Immunology, Saint Louis University School of Medicine, Saint Louis, Mo.
• ⁶⁵ Division of Allergy/Immunology, University of South Florida, Tampa, Fla.
• ⁶⁶ Nova Southeastern University, Fort Lauderdale, Fla.
• ⁶⁷ Department of Medicine, Clinical Immunology and Allergy, McMaster University, Hamilton, Ontario, Canada.
• ⁶⁸ MACVIA-France, Fondation partenariale FMC VIA-LR, Montpellier, France; University Hospital, Montpellier, France; INSERM U 1168, VIMA: Ageing and chronic diseases Epidemiological and Public Health Approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, and Euforea, Brussels, Belgium. Electronic address: [email protected].